Leading innovators are streamlining quality management across their
organizations and with external partners
PLEASANTON, Calif.--(BUSINESS WIRE)--
Modernizing quality management is becoming a top priority among leading
life sciences companies. With this shift underway, an increasing number
of organizations are unifying quality processes with Veeva
Vault Quality applications from Veeva
Systems (NYSE:VEEV). The number of Vault Quality customers has
increased to more than 180, including 10 of the top 20 largest global
pharmaceutical companies implementing Veeva
Vault QualityDocs in at least one division. Also, the number of Veeva
Vault QMS customers has nearly doubled since last year, with 58 life
sciences organizations using the application to manage quality processes.
“Collaboration and access among global stakeholders are critical to
compliance and driving operational alignment,” said Maria Conklin,
associate director, quality control, at Karyopharm
Therapeutics. “Veeva Vault Quality gives us unified applications to
manage quality documents and processes across our organization and with
partners on one cloud platform, making collaboration much more efficient
and secure.”
Vault Quality applications help streamline business processes and
content across global sites, suppliers, contract manufacturers, and
other partners to speed workflows for greater efficiency. Vault QMS,
Vault QualityDocs, and Vault
Training are part of the Vault Quality Suite, bringing together
quality processes, document control, and training on a single cloud
platform.
“There is a significant opportunity for companies to modernize quality
management and give internal and external teams greater visibility and
transparency,” said Mike Jovanis, vice president of Vault Quality at
Veeva. “With a cloud-based solution, organizations can more closely
align with partners to operate effectively and meet compliance
regulations with ease.”
Customers can also bring together Vault Quality suite with applications
for clinical and regulatory as part of Veeva
Development Cloud, a unified suite of applications that helps
organizations drive end-to-end business processes across research and
development and manufacturing.
In other news, Veeva announced that more medical devices and diagnostics
companies are adopting Veeva
Vault to streamline processes throughout the product lifecycle. Read
today’s press
releaseto learn more.
Also, join more than 1,300 life sciences professionals and experts at
the upcoming Veeva
R&D Summit in Philadelphia, September 16-18. Learn more,
register, and view the full agenda at veeva.com/R&DSummit.
Additional Information
For more on Veeva Vault Quality Suite, visit: veeva.com/VaultQuality
Connect
with Veeva on LinkedIn: linkedin.com/company/veeva-systems
Follow
@veevasystems on Twitter: twitter.com/veevasystems
Like
Veeva on Facebook: facebook.com/veevasystems
About Veeva Systems
Veeva Systems Inc. is a leader in cloud-based software for the global
life sciences industry. Committed to innovation, product excellence, and
customer success, Veeva has more than 650 customers, ranging from the
world's largest pharmaceutical companies to emerging biotechs. Veeva is
headquartered in the San Francisco Bay Area, with offices throughout
North America, Europe, Asia, and Latin America. For more information,
visit veeva.com.
Forward-looking Statements
This release contains forward-looking statements, including the market
demand for and acceptance of Veeva’s products and services, the results
from use of Veeva’s products and services, and general business
conditions, particularly in the life sciences industry. Any
forward-looking statements contained in this press release are based
upon Veeva’s historical performance and its current plans, estimates,
and expectations, and are not a representation that such plans,
estimates, or expectations will be achieved. These forward-looking
statements represent Veeva’s expectations as of the date of this press
announcement. Subsequent events may cause these expectations to change,
and Veeva disclaims any obligation to update the forward-looking
statements in the future. These forward-looking statements are subject
to known and unknown risks and uncertainties that may cause actual
results to differ materially. Additional risks and uncertainties that
could affect Veeva’s financial results are included under the captions,
“Risk Factors” and “Management’s Discussion and Analysis of Financial
Condition and Results of Operations,” in the company’s filing on Form
10-Q for the period ended July 31, 2018. This is available on the
company’s website at veeva.com
under the Investors section and on the SEC’s website at sec.gov.
Further information on potential risks that could affect actual results
will be included in other filings Veeva makes with the SEC from time to
time.
View source version on businesswire.com:
https://www.businesswire.com/news/home/20180912005353/en/
Veeva Systems
Roger Villareal, 925-264-8885
roger.villareal@veeva.com
or
Lisa
Barbadora, 610-420-3413
pr@veeva.com
Source: Veeva Systems